607 related articles for article (PubMed ID: 23427895)
1. Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.
Dettmer M; Perren A; Moch H; Komminoth P; Nikiforov YE; Nikiforova MN
Thyroid; 2013 Nov; 23(11):1383-9. PubMed ID: 23427895
[TBL] [Abstract][Full Text] [Related]
2. In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
Guo Z; Hardin H; Montemayor-Garcia C; Asioli S; Righi A; Maletta F; Sapino A; Lloyd RV
Endocr Pathol; 2015 May; 26(2):157-63. PubMed ID: 25771986
[TBL] [Abstract][Full Text] [Related]
3. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features.
Jahanbani I; Al-Abdallah A; Ali RH; Al-Brahim N; Mojiminiyi O
Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas.
Dettmer M; Vogetseder A; Durso MB; Moch H; Komminoth P; Perren A; Nikiforov YE; Nikiforova MN
J Clin Endocrinol Metab; 2013 Jan; 98(1):E1-7. PubMed ID: 23150679
[TBL] [Abstract][Full Text] [Related]
5. miRNA expression profiling of 'noninvasive follicular thyroid neoplasms with papillary-like nuclear features' compared with adenomas and infiltrative follicular variants of papillary thyroid carcinomas.
Borrelli N; Denaro M; Ugolini C; Poma AM; Miccoli M; Vitti P; Miccoli P; Basolo F
Mod Pathol; 2017 Jan; 30(1):39-51. PubMed ID: 27586203
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of five miRNAs in papillary thyroid carcinomas.
Qiao DH; He XM; Deng X; Ji YC; Yang H; Cheng L; Zhou XY
J Clin Lab Anal; 2021 Sep; 35(9):e23907. PubMed ID: 34268792
[TBL] [Abstract][Full Text] [Related]
7. In-depth characterization of the microRNA transcriptome in normal thyroid and papillary thyroid carcinoma.
Swierniak M; Wojcicka A; Czetwertynska M; Stachlewska E; Maciag M; Wiechno W; Gornicka B; Bogdanska M; Koperski L; de la Chapelle A; Jazdzewski K
J Clin Endocrinol Metab; 2013 Aug; 98(8):E1401-9. PubMed ID: 23783103
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.
Chen YT; Kitabayashi N; Zhou XK; Fahey TJ; Scognamiglio T
Mod Pathol; 2008 Sep; 21(9):1139-46. PubMed ID: 18587330
[TBL] [Abstract][Full Text] [Related]
9. Differences in miRNA expression profiles between wild-type and mutated NIFTPs.
Denaro M; Ugolini C; Poma AM; Borrelli N; Materazzi G; Piaggi P; Chiarugi M; Miccoli P; Vitti P; Basolo F
Endocr Relat Cancer; 2017 Oct; 24(10):543-553. PubMed ID: 28830935
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-based molecular classification of papillary thyroid carcinoma.
Rosignolo F; Memeo L; Monzani F; Colarossi C; Pecce V; Verrienti A; Durante C; Grani G; Lamartina L; Forte S; Martinetti D; Giuffrida D; Russo D; Basolo F; Filetti S; Sponziello M
Int J Oncol; 2017 May; 50(5):1767-1777. PubMed ID: 28393181
[TBL] [Abstract][Full Text] [Related]
11. The rs2910164 Genetic Variant of miR-146a-3p Is Associated with Increased Overall Mortality in Patients with Follicular Variant Papillary Thyroid Carcinoma.
Kotlarek M; Kubiak A; Czetwertyńska M; Świerniak M; Gierlikowski W; Kolanowska M; Bakuła-Zalewska E; Jhiang SM; Jażdżewski K; Wójcicka A
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495389
[TBL] [Abstract][Full Text] [Related]
12. Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?
Lassalle S; Hofman V; Ilie M; Bonnetaud C; Puisségur MP; Brest P; Loubatier C; Guevara N; Bordone O; Cardinaud B; Lebrigand K; Rios G; Santini J; Franc B; Mari B; Al Ghuzlan A; Vielh P; Barbry P; Hofman P
Endocr Relat Cancer; 2011 Oct; 18(5):579-94. PubMed ID: 21778212
[TBL] [Abstract][Full Text] [Related]
13. Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma.
Peng Y; Li C; Luo DC; Ding JW; Zhang W; Pan G
Molecules; 2014 Aug; 19(8):11586-99. PubMed ID: 25100252
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA deep-sequencing reveals master regulators of follicular and papillary thyroid tumors.
Mancikova V; Castelblanco E; Pineiro-Yanez E; Perales-Paton J; de Cubas AA; Inglada-Perez L; Matias-Guiu X; Capel I; Bella M; Lerma E; Riesco-Eizaguirre G; Santisteban P; Maravall F; Mauricio D; Al-Shahrour F; Robledo M
Mod Pathol; 2015 Jun; 28(6):748-57. PubMed ID: 25720323
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression profiling of RAS-mutant thyroid tumors with follicular architecture: microRNA signatures to discriminate benign from malignant lesions.
Macerola E; Poma AM; Vignali P; Proietti A; Torregrossa L; Ugolini C; Basolo A; Matrone A; Elisei R; Santini F; Basolo F
J Endocrinol Invest; 2023 Aug; 46(8):1651-1662. PubMed ID: 36749451
[TBL] [Abstract][Full Text] [Related]
16. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C
BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287
[TBL] [Abstract][Full Text] [Related]
17. Microarray profiling of circular RNAs in human papillary thyroid carcinoma.
Peng N; Shi L; Zhang Q; Hu Y; Wang N; Ye H
PLoS One; 2017; 12(3):e0170287. PubMed ID: 28288173
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma.
Yip L; Kelly L; Shuai Y; Armstrong MJ; Nikiforov YE; Carty SE; Nikiforova MN
Ann Surg Oncol; 2011 Jul; 18(7):2035-41. PubMed ID: 21537871
[TBL] [Abstract][Full Text] [Related]
19. Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma.
Li M; Song Q; Li H; Lou Y; Wang L
PLoS One; 2015; 10(7):e0132403. PubMed ID: 26168287
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA profile of poorly differentiated thyroid carcinomas: new diagnostic and prognostic insights.
Dettmer MS; Perren A; Moch H; Komminoth P; Nikiforov YE; Nikiforova MN
J Mol Endocrinol; 2014 Apr; 52(2):181-9. PubMed ID: 24443580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
